Dorian Bochaton
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Dorian Bochaton has a total of 24 co-authors. Here are the top co-authors by number of shared publications:
Agnès M. Cordonnier
Université de Strasbourg, Biotechnologie et Signalisation Cellulaire, UMR7242, CNRS, Illkirch, France
1 shared publication- Andrey A. Yurchenko
INSERM U981, Gustave Roussy Cancer Campus, Université Paris Saclay, Villejuif, France
1 shared publication - Arnault Tauziède-Espariat
Department of Neuropathology, GHU Paris - Psychiatry and Neuroscience, Sainte-Anne Hospital, Paris, France
1 shared publication Arthur Durouchoux
Department of Neurosurgery University Hospital of Bordeaux Bordeaux France
1 shared publicationBarbara Ben Yamin
Université Paris-Saclay, CNRS-UMR9019 Genome Integrity and Cancers, Gustave Roussy, Villejuif, France
1 shared publication- Basile Guignier
Université Paris-Saclay, CNRS-UMR9019 Genome Integrity and Cancers, Gustave Roussy, Villejuif, France
1 shared publication
Latest Publications
- Open Access
- 4 October 2026
- Published by Wiley in Neuropathology and Applied Neurobiology
- Vol. 52 (5)
A Case of Primary Intramedullary Infantile Fibrosarcoma With an RBPMS::NTRK3 Fusion and Response to Larotrectinib
Summary: First reported case of primary central nervous system infantile fibrosarcoma. Expansion of the molecular spectrum of infantile fibrosarcoma with identification of an RBPMS::NTRK3 fusion. Marked efficacy of larotrectinib observed in an unresectable CNS tumour. Reinforces the importance of molecular testing in atypical paediatric CNS tumours.
- 4 October 2026
- Published by Wiley in Neuropathology and Applied Neurobiology
- Vol. 52 (5)
Open AccessA Case of Primary Intramedullary Infantile Fibrosarcoma With an RBPMS::NTRK3 Fusion and Response to Larotrectinib
Summary: First reported case of primary central nervous system infantile fibrosarcoma. Expansion of the molecular spectrum of infantile fibrosarcoma with identification of an RBPMS::NTRK3 fusion. Marked efficacy of larotrectinib observed in an unresectable CNS tumour. Reinforces the importance of molecular testing in atypical paediatric CNS tumours.
- Open Access
- 15 June 2026
- Published by Springer Nature in Nature Communications
- Vol. 17 (1)
TASP1-mediated cleavage of REV3L enhances the activity of DNA polymerase ζ in mammalian cells
DNA polymerase ζ (Polζ) is essential for replication across damaged DNA, yet the mechanisms governing its regulation in mammalian cells remain incompletely understood. The catalytic subunit REV3L is nearly twice the size of its yeast counterpart owing to a large vertebrate-specific insertion, and recent studies reported that REV3L undergoes proteolytic cleavage by the endopeptidase TASP1. Here, we show that REV3L cleavage generates two stable fragments, Nter-p70 and Cter-p300, which reassociate into a long-lived heterodimeric complex with enhanced polymerase activity. This interaction is stabilized by key residues within the catalytically inactive EXO domain. The cleaved Polζ complex associates with chromatin, binds nascent DNA, and undergoes ATR-dependent phosphorylation in response to replication stress. Importantly, preventing REV3L cleavage markedly impairs Polζ activity, reduces cisplatin-induced mutagenesis, and increases RAD51 nuclear foci and sister chromatid exchange, consistent with a compensatory shift toward homologous recombination-mediated repair. Together, our findings suggest that the vertebrate-specific expansion of REV3L necessitated cleavage to restore structural organization and optimize catalytic function, representing an evolutionary adaptation in DNA damage tolerance pathways.
- 15 June 2026
- Published by Springer Nature in Nature Communications
- Vol. 17 (1)
Open AccessTASP1-mediated cleavage of REV3L enhances the activity of DNA polymerase ζ in mammalian cells
DNA polymerase ζ (Polζ) is essential for replication across damaged DNA, yet the mechanisms governing its regulation in mammalian cells remain incompletely understood. The catalytic subunit REV3L is nearly twice the size of its yeast counterpart owing to a large vertebrate-specific insertion, and recent studies reported that REV3L undergoes proteolytic cleavage by the endopeptidase TASP1. Here, we show that REV3L cleavage generates two stable fragments, Nter-p70 and Cter-p300, which reassociate into a long-lived heterodimeric complex with enhanced polymerase activity. This interaction is stabilized by key residues within the catalytically inactive EXO domain. The cleaved Polζ complex associates with chromatin, binds nascent DNA, and undergoes ATR-dependent phosphorylation in response to replication stress. Importantly, preventing REV3L cleavage markedly impairs Polζ activity, reduces cisplatin-induced mutagenesis, and increases RAD51 nuclear foci and sister chromatid exchange, consistent with a compensatory shift toward homologous recombination-mediated repair. Together, our findings suggest that the vertebrate-specific expansion of REV3L necessitated cleavage to restore structural organization and optimize catalytic function, representing an evolutionary adaptation in DNA damage tolerance pathways.